https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/international-aids-conference
PrEP (HIV Pre-Exposure Prophylaxis)

International AIDS Conference

The Latest

Assessing Benefits of Pre-Exposure Prophylaxis Relative to Risks of Drug Resistance Img

Assessing Benefits of Pre-Exposure Prophylaxis Relative to Risks of Drug Resistance

"Resistant infections during PrEP [pre-exposure prophylaxis] should be weighed against the numbers of infections averted," stated renowned HIV prevention and PrEP (pre-exposure prophylaxis) researcher Robert Grant, M.D., M.P.H., during a PrEP-focused...

Making PrEP More Integrated and Available for Primary Care Providers to Prescribe in the U.S. Southeast Img

Making PrEP More Integrated and Available for Primary Care Providers to Prescribe in the U.S. Southeast

Jessica Seidelman, M.D., and her Duke colleagues want to empower primary care providers in the U.S. Southeast to tell their patients, "[PrEP] is something that you can take.

PrEP Studies at AIDS 2016: Includes First Preclinical Data With EFdA Img

PrEP Studies at AIDS 2016: Includes First Preclinical Data With EFdA

Pre-exposure prophylaxis (PrEP) was a major theme at the 21st International AIDS Conference with probably more oral presentations and posters than any other subject.

PrEP and rainbow flag

On-Demand PrEP Effective Among MSM, but High Rates of STIs Observed

Taking pre-exposure prophylaxis (PrEP) "on demand," meaning only around the time of sexual intercourse was effective in preventing HIV infection among men who have sex with men (MSM), Jean-Michel Molina, M.D., of the University of Paris Diderot repor...

Rilpivirine as HIV PrEP Remains in Body 18 Months After Single Long-Acting Shot Img

Rilpivirine as HIV PrEP Remains in Body 18 Months After Single Long-Acting Shot

Rilpivirine (Edurant) remained detectable in plasma and female genital tract fluids for 18 months or more after a single injection of a long-acting non-nucleoside for HIV pre-exposure prophylaxis (PrEP).

Nurse-Led PrEP Clinic in San Francisco Shares Model of Success at AIDS 2016 Img

Nurse-Led PrEP Clinic in San Francisco Shares Model of Success at AIDS 2016

A program by San Francisco AIDS Foundation uses a nurse-led model of care to provide free, easy-to-access PrEP services to cisgender and transgender men who have sex with men.

Oral Maraviroc PrEP Protects U.S. Women From HIV in 48-Week Study Img

Oral Maraviroc PrEP Protects U.S. Women From HIV in 48-Week Study

No woman taking daily maraviroc pre-exposure prophylaxis (PrEP) with or without tenofovir (TDF, Viread) or emtricitabine (FTC, Emtriva) became infected with HIV through 48 weeks in a randomized, double-blind, 188-woman U.S. study.

Taking a Look at PrEP by the Numbers: Unpacking the iPrEx OLE Study (Infographic) Img

Taking a Look at PrEP by the Numbers: Unpacking the iPrEx OLE Study (Infographic)

The iPrEx OLE study told us a lot about the effectiveness of PrEP, and this infographic goes over the major data points you need to know if you are planning to use or prescribe PrEP.

AIDS 2014: Ed Ngoksin on PrEP and the WHO Guidelines (Video) Img

AIDS 2014: Ed Ngoksin on PrEP and the WHO Guidelines (Video)

IFARA interviewed Ed Ngoksin, a member of the World Health Organization's guidelines committee, about the new WHO guidelines and their recommendation for pre-exposure prophylaxis for men who have sex with men.

Open-Label Oral PrEP at 4 Doses a Week: Why Zero Infections Does Not Equal 100% Efficacy Img

Open-Label Oral PrEP at 4 Doses a Week: Why Zero Infections Does Not Equal 100% Efficacy

One of the most important advances at AIDS 2014 was a late-breaker study on open label use of oral PrEP, presented by Robert Grant from UCSF.